1
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
Condition(s):Advanced CancerLast Updated:December 11, 2019Active, not recruiting
Zyprexa: 478 Clinical Trials, Page 1 of 48
Hide Studies Not Open or Pending
2
Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:April 7, 2020Completed
3
A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
Condition(s):Idiopathic GastroparesisLast Updated:September 10, 2019Terminated
4
Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study
Condition(s):FedLast Updated:January 5, 2012Completed
5
Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy’s Under Fasting Conditions
Condition(s):FastingLast Updated:January 5, 2012Completed
6
Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition
Condition(s):FedLast Updated:January 5, 2012Completed
7
Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition
Condition(s):FastingLast Updated:January 5, 2012Completed
8
Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care
Condition(s):Nausea; Vomiting; End Stage CancerLast Updated:September 20, 2018Recruiting
9
Olanzapine for Acute Headaches
Condition(s):HeadacheLast Updated:August 20, 2019Completed
10
Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:November 23, 2016Unknown status